Nuvalent (NUVL) Reiterated at Buy by Stifel on Ph1/2 ALKOVE-1 study Data
Tweet Send to a Friend
Stifel analyst Laura Prendergast reiterated a Buy rating and $135.00 price target on Nuvalent (NASDAQ: NUVL).The analyst commented, "NUVL presented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


